Sweden Pharmaceutical Market Share

Statistics for the 2023 & 2024 Sweden Pharmaceutical market share, created by Mordor Intelligence™ Industry Reports. Sweden Pharmaceutical share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Sweden Pharmaceutical Industry

The Sweden pharmaceutical market is highly competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the key companies that are currently dominating the market are AbbVie Inc., Merck & Co., Inc., Amgen Inc., Pfizer Inc., and GlaxoSmithKline plc.

Sweden Pharmaceutical Market Leaders

  1. Amgen Inc.

  2. Pfizer Inc.

  3. Novartis International AG

  4. Orifarm Group A/S

  5. Merck & Co., Inc.

*Disclaimer: Major Players sorted in no particular order

AbbVie Inc., Merck & Co., Inc., Amgen Inc., Pfizer Inc., and GlaxoSmithKline plc.

Sweden Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)